4 completed. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 3 |
Follow UV1: new trials by email Literature Review of UV1 trials Research Report on UV1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma UV1, GM-CSF - Malignant Melanoma | Phase 1 | Completed | Ultimovacs ASA | 30 | 2018-07-09 | 2024-08-22 |
| Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma Ipilimumab, UV1 vaccine, GM-CSF - Malignant Melanoma | Phase 1 / Phase 2 | Completed | Ultimovacs ASA | 12 | 2015-02-02 | 2024-12-16 |
| A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer UV1 synthetic peptide vaccine and GM-CSF - Prostate Cancer | Phase 1 / Phase 2 | Completed | Ultimovacs ASA | 22 | 2013-04-15 | 2024-12-16 |
| A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. UV1 synthetic peptide vaccine and GM-CSF - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Ultimovacs ASA | 18 | 2013-04-08 | 2024-12-16 |
Melanoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasms (1) · Prostatic Neoplasms (1)
Ultimovacs ASA (4)
Norway (3) · United States (1)
Paal F. Brunsvig, MD PhD (1) · Tormod Guren, MD PhD (1) · Wolfgang Lilleby, MD PhD (1)